WUXI XDC(02268),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02268 WUXI XDC

Not Yet Opened 01-15 16:08:10

72.900

-2.850

-3.76%

High75.450	Low72.100	Vol6.21M
Open74.000	D1 Closing75.750	Amplitude4.42%
Mkt Cap91.49B	Tradable Cap91.49B	Total Shares1.26B
T/O455.40M	T/O Rate0.49%	Tradable Shares1.26B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02268","market":"HK","secType":"STK","nameCN":"WUXI XDC","latestPrice":72.9,"timestamp":1768464490005,"preClose":75.75,"halted":0,"volume":6208731,"delay":0,"floatShares":1255000000,"shares":1255000000,"eps":0.9994898206797607,"marketStatus":"Not Yet Opened","change":-2.85,"latestTime":"01-15 16:08:10","open":74,"high":75.45,"low":72.1,"amount":455400055,"amplitude":0.044224,"askPrice":72.9,"askSize":6000,"bidPrice":72.8,"bidSize":51000,"shortable":3,"etf":0,"ttmEps":1.1429178440402021,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1768527000000},"marketStatusCode":0,"adr":0,"listingDate":1700150400000,"exchange":"SEHK","adjPreClose":75.75,"openAndCloseTimeList":[[1768440600000,1768449600000],[1768453200000,1768464000000]],"volumeRatio":1.246926,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02268","defaultTab":"news","newsList":[{"id":"2603622754","title":"WuXi XDC Launches Takeover Offer for BioDlink International, Forecasts Rise in 2025 Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=2603622754","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603622754?lang=en_us&edition=fundamental","pubTime":"2026-01-15 11:21","pubTimestamp":1768447295,"startTime":"0","endTime":"0","summary":"WuXi XDC (HKG:2268) made an offer to acquire BioDlink International (HKG:1875) for HK$4 per share in cash, according to a joint statement Wednesday.Shares of the contract research, development and man","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0516422366.SGD","LU2039709279.SGD","BK1161","LU0823426480.USD","IE00B0JY6N72.USD","02269","LU0326950275.SGD","LU0823426308.USD","LU0417516902.SGD","SG9999002463.SGD","LU0052750758.USD","BK1589","02268","LU0708995583.HKD","SG9999002562.SGD","LU0043850808.USD","LU0516422440.USD","LU0039217434.USD","BK1576","LU0348825331.USD","LU0417516738.SGD","BK1521","LU0516423091.SGD","LU0359202008.SGD","BK1574","BK1610","LU1720050803.USD","LU1880383366.USD","LU3063872942.SGD","LU0979878070.USD","SG9999014674.SGD","LU0051755006.USD","LU0359201612.USD","LU0572944931.SGD","LU1688375341.USD","LU1794554557.SGD","LU2488822045.USD","LU0140636845.USD","LU0456846285.SGD","LU0819121731.USD","LU0516423174.USD","LU0307460666.USD","LU0516422952.EUR","LU1242518931.SGD","01875","LU0456827905.SGD","BK1141","LU0856984785.SGD","LU0588546209.SGD","LU0320764599.SGD"],"gpt_icon":0},{"id":"1161056463","title":"Zhutong Hong Kong Stock Morning Briefing | Ministry of Finance Holds Meeting on Fiscal-Financial Synergy to Boost Domestic Demand; White House Announces 25% Tariff Hike on Specific Semiconductors","url":"https://stock-news.laohu8.com/highlight/detail?id=1161056463","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161056463?lang=en_us&edition=fundamental","pubTime":"2026-01-15 07:55","pubTimestamp":1768434913,"startTime":"0","endTime":"0","summary":"On the afternoon of January 13th, the Ministry of Finance, in conjunction with relevant departments, convened a nationwide video conference to advance the package of policies aimed at promoting...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1610","BK1615","09961","BK1516","BK1589","SOXX","SMH","LU1720050803.USD","BK1502","BK4588","300759","01875","BK1521","BK1564","WXXWY","BK1571","BK1147","BK1617","BK4585","03759","LU1794554557.SGD","BK1501","TCOM","BK1142","BK1515","BK1189","BK1584","02268","02269","BK1591","09688","BK1247","ZLAB"],"gpt_icon":1},{"id":"1114069729","title":"Strong Earnings and Acquisition of TOT Biopharm Bolster WUXI XDC's (02268) Position in ADC CDMO Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1114069729","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114069729?lang=en_us&edition=fundamental","pubTime":"2026-01-14 23:39","pubTimestamp":1768405156,"startTime":"0","endTime":"0","summary":"On January 14, 2026, WUXI XDC (02268) issued a positive profit alert for its 2025 fiscal year and simultaneously disclosed its launch of a voluntary conditional cash offer to acquire TOT Biopharm....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4080","BK4139","BK1141","02268","LU2488822045.USD","SG9999014674.SGD","BK4231","ADC","CDMO"],"gpt_icon":0},{"id":"1137624204","title":"Hong Kong Stock Announcement Highlights | BIODLINK-B Receives 99% Premium Cash Offer from WUXI XDC, Resumes Trading on January 15","url":"https://stock-news.laohu8.com/highlight/detail?id=1137624204","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137624204?lang=en_us&edition=fundamental","pubTime":"2026-01-14 23:14","pubTimestamp":1768403671,"startTime":"0","endTime":"0","summary":"Major Developments: Longqi Technology (09611) will conduct its IPO from January 14 to January 19, planning a global offering of 52.2591 million H shares. Hutchmed (00013) announced that the results...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1720050803.USD","BK1141","06887","00998","BK1147","LU1497734951.SGD","06030","BK1560","LU0051755006.USD","BK1574","LU0456827905.SGD","LU0572940350.SGD","HK0000500386.USD","LU0210526637.USD","LU0264606111.USD","BK1191","SG9999014674.SGD","BK1231","LU1634259391.SGD","09887","LU0572939691.SGD","01875","LU1794554557.SGD","BK1564","LU1522347837.USD","HK0000252152.HKD","BK1516","BK1521","LU1497733557.USD","HK0000252160.HKD","LU1497733631.SGD","02268","LU2488822045.USD","BK1161","LU1634259557.SGD"],"gpt_icon":0},{"id":"2603617138","title":"BioDlink International Says WuXi XDC Cayman To Make Conditional Cash Offer For All Co Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2603617138","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603617138?lang=en_us&edition=fundamental","pubTime":"2026-01-14 23:11","pubTimestamp":1768403515,"startTime":"0","endTime":"0","summary":"Jan 14 (Reuters) - BioDlink International Co Ltd <1875.HK>::*CITI TO MAKE VOLUNTARY CONDITIONAL CASH OFFER FOR ALL ISSUED SHARES*OFFER PRICE OF HK$4.00/ OFFER SHARE*OFFER FOR ALL ISSUED SHARES OF CO O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nRSD96SvDP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2462157665.USD","LU0326950275.SGD","LU2236285917.USD","LU0823426480.USD","LU0417516902.SGD","02269","LU0819121731.USD","LU0708995583.HKD","LU0327786744.USD","LU1242518931.SGD","LU1162221912.USD","LU2488822045.USD","BK4207","BK4559","LU0456846285.SGD","SG9999014674.SGD","LU0456827905.SGD","LU0140636845.USD","IE00B0JY6N72.USD","LU0051755006.USD","BK4504","LU2456880835.USD","LU1688375341.USD","LU0072461881.USD","LU0979878070.USD","SG9999002562.SGD","LU0348735423.USD","LU2125154778.USD","LU0170899867.USD","LU1267930227.SGD","LU0477156953.USD","BK1610","LU0348825331.USD","BK1589","LU0980610538.SGD","SG9999002463.SGD","LU0856984785.SGD","02268","LU0106831901.USD","LU1244550577.SGD","LU2125154935.USD","LU1794554557.SGD","LU0516423091.SGD","LU0516423174.USD","LU0130517989.USD","BK4585","LU0162691827.USD","LU0572944931.SGD","LU2039709279.SGD","LU0039217434.USD"],"gpt_icon":0},{"id":"1168795648","title":"BIODLINK-B (01875) Receives Cash Offer from WUXI XDC (02268) at Approximately 99% Premium, Trading Resumes January 15","url":"https://stock-news.laohu8.com/highlight/detail?id=1168795648","media":"Stock News","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168795648?lang=en_us&edition=fundamental","pubTime":"2026-01-14 23:08","pubTimestamp":1768403307,"startTime":"0","endTime":"0","summary":"BIODLINK-B (01875) and the offeror, WUXI XDC (02268), have jointly announced that on January 14, 2026, the Board was informed by the offeror that Citigroup will make a voluntary conditional cash...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","LU2488822045.USD","01875","SG9999014674.SGD","BK1141","02268","BK1161"],"gpt_icon":0},{"id":"1102489667","title":"WUXI XDC (02268) Issues Profit Alert, Anticipates 2025 Net Profit to Surge Over 38%","url":"https://stock-news.laohu8.com/highlight/detail?id=1102489667","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102489667?lang=en_us&edition=fundamental","pubTime":"2026-01-14 23:00","pubTimestamp":1768402851,"startTime":"0","endTime":"0","summary":"WUXI XDC (02268) has announced its projected financial performance for the fiscal year ending December 31, 2025. The Group anticipates achieving the following results: (1) Revenue: an increase of...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268","LU2488822045.USD","SG9999014674.SGD","BK1141"],"gpt_icon":0},{"id":"2603612095","title":"WuXi XDC Cayman Launches Voluntary Cash Offer for All Outstanding Shares and Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2603612095","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603612095?lang=en_us&edition=fundamental","pubTime":"2026-01-14 22:57","pubTimestamp":1768402640,"startTime":"0","endTime":"0","summary":"Citigroup Global Markets Asia Limited, on behalf of the offeror, has launched voluntary conditional cash offers to acquire all issued shares of WuXi XDC Cayman Inc. that are not already owned or agreed to be acquired by the offeror and its concert parties, as well as to cancel all outstanding share options. WuXi Biologics, the controlling shareholder of the offeror, has provided written approval for the offers and the related transactions. A circular with further details and recommendations from the directors of the offeror is expected to be sent to WuXi XDC shareholders on or before February 4, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wuxi XDC Cayman Inc. published the original content used to generate this news brief via ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nNDLzQq8c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1162221912.USD","02268","BK4588","LU0052756011.USD","LU0106831901.USD","LU1794554557.SGD","LU0052750758.USD","BK4566","LU0456846285.SGD","LU0856984785.SGD","LU0588546209.SGD","LU0310800965.SGD","LU2488822045.USD","BK4207","SG9999002562.SGD","BK1589","LU0359202008.SGD","LU0417516738.SGD","IE00BSNM7G36.USD","LU0043850808.USD","LU0979878070.USD","LU0039217434.USD","LU1242518931.SGD","LU3063872942.SGD","02269","LU1880383366.USD","LU0348735423.USD","BK4534","BK4585","SG9999014674.SGD","BK1610","LU0819121731.USD","BK4559","LU0128525689.USD","LU0359201612.USD","LU0098860793.USD","LU0516422440.USD","BK1576","LU1366192091.USD","LU0348825331.USD","LU0170899867.USD","LU0516422952.EUR","LU1267930227.SGD","LU1791807156.HKD","SG9999002463.SGD","LU1242518857.USD","LU0516423174.USD","LU0823426308.USD","LU0320764599.SGD","LU0307460666.USD"],"gpt_icon":0},{"id":"2603612750","title":"WuXi XDC Cayman Inc - FY Revenue Expected to Increase by More Than 45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603612750","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603612750?lang=en_us&edition=fundamental","pubTime":"2026-01-14 22:51","pubTimestamp":1768402287,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nFWN3YF1VB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","SG9999014674.SGD","02268","LU2488822045.USD"],"gpt_icon":0},{"id":"2603261275","title":"WuXi XDC Cayman Inc Sees FY Net Profit to Increase by More Than 38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603261275","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603261275?lang=en_us&edition=fundamental","pubTime":"2026-01-14 22:51","pubTimestamp":1768402287,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nFWN3YF1VB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999014674.SGD","LU2488822045.USD","BK1141","02268"],"gpt_icon":0},{"id":"2603127956","title":"WuXi XDC Cayman Expects Net Profit to Rise Over 38% for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2603127956","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603127956?lang=en_us&edition=fundamental","pubTime":"2026-01-14 22:51","pubTimestamp":1768402282,"startTime":"0","endTime":"0","summary":"WuXi XDC Cayman Inc. has announced that, based on preliminary unaudited management accounts for the year ended December 31, 2025, the group expects to record remarkable growth in key financial performance indicators. Notably, the company anticipates that both gross profit and adjusted financial measures will grow at rates significantly higher than revenue, reflecting enhanced operational efficiency and profitability. Net profit is expected to increase by more than 38% compared to the previous year, despite adverse impacts from foreign exchange and interest rate movements. Final annual results are yet to be finalized and are expected to be published on or about March 23, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wuxi XDC Caym","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nNDL8GpLxJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1576","LU0588546209.SGD","LU0140636845.USD","BK1610","LU0823426480.USD","LU0516422366.SGD","02269","LU0359201612.USD","LU3063872942.SGD","SG9999002463.SGD","LU0417516902.SGD","LU0051755006.USD","LU0819121731.USD","LU0516423091.SGD","LU0516422952.EUR","LU1688375341.USD","LU0348825331.USD","LU1720050803.USD","BK1141","LU0043850808.USD","LU0516423174.USD","LU1242518931.SGD","LU1242518857.USD","LU0039217434.USD","BK1589","LU2039709279.SGD","LU0417516738.SGD","LU0052750758.USD","BK1521","LU0979878070.USD","LU0327786744.USD","LU0359202008.SGD","02268","LU0516422440.USD","LU0856984785.SGD","SG9999014674.SGD","LU0456827905.SGD","LU0456846285.SGD","LU0348735423.USD","SG9999002562.SGD","LU2488822045.USD","LU1880383366.USD","LU0572944931.SGD","LU0320764599.SGD","LU0307460666.USD","LU0708995583.HKD","LU0181495838.USD","LU0326950275.SGD","LU0823426308.USD","IE00B0JY6N72.USD"],"gpt_icon":0},{"id":"1133811487","title":"Gelonghui's 2026 \"Bet on China\" Top 10 Core Assets List, Officially Revealed!","url":"https://stock-news.laohu8.com/highlight/detail?id=1133811487","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133811487?lang=en_us&edition=fundamental","pubTime":"2026-01-01 04:31","pubTimestamp":1767213088,"startTime":"0","endTime":"0","summary":"The 2026 annual \"Bet on China\" Top 10 Core Assets, voted by tens of millions of members across more than seventy countries, has been officially unveiled amidst a market shrouded in \"uncertainty\"!...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1251922891.USD","IE0003851619.USD","BK1589","LU0348814723.USD","LU0577902298.EUR","LU0132412106.USD","LU0214875030.USD","LU0819121731.USD","LU1044874839.SGD","LU0169518387.USD","LU1642822792.SGD","LU2237443549.SGD","BK1586","LU1804176565.USD","SG9999001093.SGD","LU0823413587.USD","LU0070217475.USD","LU0359202008.SGD","SG9999018857.SGD","LU0449515922.USD","LU0762540952.USD","BK1095","LU2317271919.USD","LU2348773727.SGD","IE00B031J352.USD","SG9999001069.SGD","BK1591","LU1115378108.SGD","TCOM","BK1164","LU2251237306.USD","LU0630378692.HKD","LU1226288253.USD","LU0211331839.USD","LU1961090484.USD","SG9999015952.SGD","LU0348816934.USD","LU0865486749.SGD","LU0072913022.USD","LU0577902538.SGD","SG9999014674.SGD","IE00B0JY6N72.USD","LU0054237671.USD","LU1725190679.HKD","LU0149721374.USD","LU0469268626.HKD","LU1323998911.USD","LU0181495838.USD","LU2177674079.SGD","IE0008368304.USD","BK1517","LU1974910355.USD","SGXZ31699556.SGD","LU0608807946.USD","LU0572939691.SGD","LU0293314216.USD","LU0821914370.USD","LU2226246903.HKD","BK1516","LU0048388663.USD","LU0254981946.USD","LU1051769294.HKD","LU0878004406.USD","IE0003895053.USD","LU0228367735.SGD","LU2237443465.HKD","SG9999002463.SGD","LU1226287792.SGD","IE00B0169L03.USD","LU0588546209.SGD","BK1604","LU0499858438.USD","LU2097828557.USD","IE0032834883.USD","LU0502904849.HKD","LU0541501648.USD","IE00BF5LJ272.USD","LU0823041008.USD","LU0320764243.SGD","LU0188438112.USD","HK0000306701.USD","LU0828238088.HKD","LU1981816686.USD","LU0856984785.SGD","BK1141","LU0683595622.HKD","LU0431992006.USD","LU2449936058.SGD","IE00BMPRXR70.SGD","LU0348783662.USD","LU0106959298.USD","LU2279701549.SGD","LU0067412154.USD","LU0784639295.USD","LU2237443978.SGD","LU0828237510.HKD","LU0084288322.USD","603993","IE0001KFT4U8.USD","518880","LU0096374516.USD","LU0149534421.HKD","LU1813983027.USD","BK1588","LU0531970944.HKD","LU0441854154.USD","LU0589944569.HKD","BK1587","89988","SG9999000327.SGD","IE00B8L5B284.USD","LU1831875114.USD","LU1044876610.USD","SG9999014880.SGD","SG9999014898.SGD","LU0672654166.SGD","LU1993786604.SGD","LU2152927971.USD","LU0831093199.SGD","LU0651946864.USD","IE0032431581.USD","LU0314109678.HKD","LU1720050803.USD","SG9999000459.SGD","LU0320764755.SGD","LU0823040885.USD","LU0315178854.USD","TCEHY","LU0128522157.USD","IE00B8HQ1Z84.USD","GB00BDT5M118.USD","LU0173614495.USD","LU1048484197.HKD","LU2251237488.HKD","LU2399975544.HKD","LU0708995153.HKD","LU0823038988.USD","LU0985320562.USD","LU0345769631.USD","LU1568876335.HKD","LU0143863198.USD","LU2362541513.USD","LU1196710351.USD","IE0008368742.USD","IE00B97KM107.HKD","IE00BMPRXN33.USD","PNGAY","BK1531","IE00B0169N27.USD","LU1868837565.USD","LU1720051017.SGD","LU0048597586.USD","IE00BZ08YT58.USD","LU0762541174.USD","LU0577902371.SGD","LU0289960550.SGD","LU1769817179.HKD","LU0979878070.USD","LU0642271901.SGD","BK1609","IE0008368411.USD","LU0047713382.USD","LU0516422952.EUR","BK1501","LU0264606111.USD","LU1481107354.HKD","IE0009570106.USD","LU0737861699.HKD","LU0029875118.USD","IE00B29SXG58.USD","LU1226288097.SGD","LU0918141887.USD","LU1568876251.USD","LU0307460666.USD","02318","HK0000320264.USD","LU1720051108.HKD","03993","LU2106854487.HKD","LU0164880469.USD","LU0061477393.USD","LU0106259558.USD","LU0164872284.USD","LU1880398554.USD","LU0117841782.USD","LU0516422366.SGD","SG9999014906.USD","LU0456842615.SGD","SG9999014914.USD","LU0348723411.USD","LU0823039010.USD","LU0417516738.SGD","LU0229945570.USD","LU0348825331.USD","LU0898667661.SGD","LU0509642566.USD","SG9999007991.SGD","LU0029874905.USD","LU1769817096.USD","LU0417516902.SGD","LU0163747925.USD","LU1655091459.SGD","09961","LU0449509016.USD","LU0456827905.SGD","LU0607220059.USD","600309","BK1615","LU0345776255.USD","LU1868838027.USD","LU0611395673.USD","LU0823413660.USD","LU0164865239.USD","LU0456846285.SGD","LU0052750758.USD","LU2265009873.SGD","LU0634319403.HKD","LU1794554557.SGD","IE00B3M56506.USD","LU0572944931.SGD","LU1226287875.USD","IE00B067MR52.USD","02268","LU1328615791.USD","LU0791591158.USD","LU0231483743.USD","BK1575","HBBD.SI","LU2247934214.USD","LU0648000940.SGD","LU1188198961.HKD","LU1196710864.SGD","SG9999000418.SGD","LU1303224171.USD","LU0791590937.USD","LU0873338254.USD","SG9999001051.SGD","LU0235996351.USD","LU0072462343.USD","LU1242518857.USD","SG9999013353.USD","LU0417516571.SGD","IE00B031HW06.USD","LU0588545730.USD","LU0593848301.USD","LU1880398471.USD","SGXZ90724238.SGD","LU0823397103.USD","LU1023057109.AUD","LU0251143458.SGD","SG9999001846.SGD","LU0261947096.USD","LU2257852520.SGD","LU0192582467.USD","LU2237443382.USD","LU0143863784.USD","BK1502","IE0031814852.USD","LU0348735423.USD","LU1211504680.USD","LU0823397285.USD","LU0823426480.USD","LU0048580855.USD","LU1629966141.USD","LU1810669033.SGD","IE00BQXX3C00.GBP","LU1282649067.USD","LU0633140727.USD","IE00BGV7N243.SGD","LU0882747503.HKD","SG9999011746.SGD","LU1808992512.USD","IE00BPRC5H50.USD","LU1328277881.USD","LU1226287529.USD","LU0348784397.USD","LU1051768304.USD","LU1785774172.SGD","LU0261950470.USD","SG9999015978.USD","LU0543330566.HKD","LU0868486357.SGD","LU1770034418.SGD","LU2097828631.EUR","LU1044875133.USD","LU1196710195.USD","LU1226288170.HKD","LU0396098781.USD","LU1008478684.HKD","LU0594300419.USD","SG9999006514.SGD","LU0463099449.HKD","LU0477156797.USD","LU2008162690.USD","LU0049112450.USD","LU0823426308.USD","LU0320764599.SGD","LU0516423091.SGD","LU0165289439.USD","601318","LU0455707207.USD","LU0128522744.USD","LU0211977185.USD","LU1548497426.USD","HK0000320223.HKD","LU1102505929.USD","SG9999003461.SGD","LU0384037296.USD","LU2237443622.USD","LU1880383440.USD","SGXZ51526630.SGD","LU1102505762.USD","300308","LU2424517915.HKD","LU0370786039.SGD","LU0287142896.SGD","LU0051755006.USD","LU2087589342.USD","LU0831103253.SGD","LU2153591404.USD","LU0210527791.USD","LU1504937902.USD","LU0197773160.USD","IE0003795394.USD","LU0197773673.USD","LU0577902454.USD","LU0700851271.USD","LU0348805143.USD","LU0269904917.USD","LU2133065610.SGD","BK1521","LU1733274473.HKD","LU0203347892.USD","LU1439102457.SGD","TCHmain","LU1675838814.USD","00700","SG9999002562.SGD","LU0650527681.SGD","LU0605514214.HKD","BK1584","LU1951186391.HKD","LU0588545490.SGD","LU0878005551.USD","LU0633140560.USD","LU0540923850.HKD","LU1282648689.USD","LU0516422440.USD","LU2778985437.USD","IE0008369823.USD","LU0608807433.USD","BK1610","LU2023250504.SGD","LU0244354667.USD","LU2125910849.SGD","LU0762542818.HKD","BABA","LU2097828474.EUR","BK1249","LU0130103400.USD","LU0531971595.HKD","LU0011963245.USD","LU1105468828.SGD","LU1734074674.USD","LU1883866441.USD","SG9999018865.SGD","LU2488822045.USD","LU0210533765.USD","LU0048575426.USD","LU0871576103.HKD","LU2362540622.SGD","LU1224709979.USD","LU0196878994.USD","LU1814569148.SGD","LU0326950275.SGD","SG9999001689.USD","SG9999000475.SGD","LU2125910500.SGD","LU1048588211.SGD","LU0819123356.HKD","LU2293587155.HKD","LU1917777945.USD","LU0651947912.USD","LU0259732245.USD","LU0175139822.USD","LU0345769128.USD","LU1242518931.SGD","LU0862451753.SGD","LU2051468812.USD","BK1608","LU0328353924.USD","LU0359201885.HKD","300059","LU0414403682.SGD","IE00BZ08YR35.GBP","LU0862451837.USD","LU1366334578.USD","IE0034224299.USD","LU0488056044.USD","LU0630378429.USD","LU2362541273.HKD","SG9999001903.USD","IE00B031HY20.USD","LU0043850808.USD","ALBmain","LU2498475776.HKD","BK1142","IE00B543WZ88.USD","LU2039709279.SGD","LU0107464264.USD","LU0648948544.HKD","LU0261950983.USD","LU0315179316.USD","SG9999017495.SGD","LU1366334651.USD","LU1515016050.SGD","LU2357305700.SGD","LU0326948709.USD","LU0594300179.USD","LU0541502299.USD","LU0130518102.USD","LU0572940350.SGD","LU1282649141.HKD","LU0117844026.USD","LU0106252389.USD","LU0588545904.SGD","LU0228659784.USD","LU1807302812.USD","SG9999015986.USD","SG9999004220.SGD","LU1960683339.HKD","09988","LU0737861772.HKD","LU1880383366.USD","LU0329678170.USD","LU0640798160.USD","LU1718418525.SGD","LU0501845795.SGD","LU1868837722.USD","IE00BQXX3D17.EUR","LU2237443895.HKD","LU0054450605.USD","LU0359201612.USD","LU1046422090.SGD","LU0203345920.USD","LU0348788117.USD","LU1770036033.HKD","LU1439103000.SGD","SGXZ99366536.SGD","SG9999015945.SGD","LU0738912210.USD","LU0210526637.USD","LU2476274720.SGD","SG9999001226.SGD","LU0345775950.USD","LU0561508036.HKD","LU0880133367.SGD","LU1224444064.USD","LU1152091168.USD","LU0577902611.USD","IE00B5MMRT66.SGD","LU2045819591.USD","LU0140636845.USD","LU2097829019.USD","LU1282651121.HKD","LU1733274390.USD","LU0543330483.HKD","LU0890818403.SGD","LU0251144936.SGD","LU2097828805.USD","LU0049853897.USD","HTCD.SI","LU0348783233.USD","LU0797268264.HKD","LU1316542783.SGD","BK1526","LU0127658192.USD","LU0886674414.USD","LU0918141705.HKD","LU3063872942.SGD","HK0000306685.HKD","LU0080751232.USD","LU1282649810.SGD","LU2242644610.SGD","LU2097828714.EUR","LU2462611646.USD","LU0327786744.USD","LU1282651048.USD","LU0499858602.USD","BK1618","LU2476274308.USD","LU0516423174.USD","LU0039217434.USD","SG9999002828.SGD","LU0348827113.USD","LU1152091754.HKD","SGXZ81514606.USD","LU0972618739.USD","LU1048596156.SGD","LU0675040207.SGD","LU0329678337.USD","LU0708995583.HKD","IE00BQXX3F31.USD","LU0828237940.HKD","LU1688375341.USD","LU1201861165.SGD","LU1719994722.HKD","SG9999006597.SGD","LU0786609619.USD","IE00BZ08YS42.EUR","LU1235295612.USD","LU1956131251.USD"],"gpt_icon":1},{"id":"2595302721","title":"This WuXi XDC Cayman Insider Reduced Their Stake By 100%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595302721","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595302721?lang=en_us&edition=fundamental","pubTime":"2025-12-31 14:24","pubTimestamp":1767162242,"startTime":"0","endTime":"0","summary":"Looking at WuXi XDC Cayman Inc.'s ( HKG:2268 ) insider transactions over the last year, we can see that insiders were...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2268/wuxi-xdc-cayman-shares/news/this-wuxi-xdc-cayman-insider-reduced-their-stake-by-100","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2268/wuxi-xdc-cayman-shares/news/this-wuxi-xdc-cayman-insider-reduced-their-stake-by-100","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2488822045.USD","02268","SG9999014674.SGD","BK1141"],"gpt_icon":0},{"id":"2595271831","title":"Akari Therapeutics Partners with WuXi XDC to Advance ADC Candidate Toward Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2595271831","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595271831?lang=en_us&edition=fundamental","pubTime":"2025-12-30 22:15","pubTimestamp":1767104124,"startTime":"0","endTime":"0","summary":"Akari Therapeutics plc has entered into a partnership with WuXi XDC to advance the manufacturing of its lead antibody drug conjugate , AKTX-101. This collaboration aims to produce GMP-grade clinical product to support upcoming Phase 1 clinical trials, planned for late 2026 or early 2027, pending regulatory clearance. WuXi XDC, recognized as a global leader in ADC development and manufacturing, will play a key role in helping Akari transition from a preclinical discovery company to a clinical-stage biotechnology player.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Akari Therapeutics plc published the original content used to generate this news brief via GlobeNewswire  on December 30, 2025, and is solely responsible for the information","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nNDL99XSfJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","SG9999014039.USD","LU0051755006.USD","BK4588","BK4112","BK1589","LU0140636845.USD","LU1720050803.USD","AKTX","SG9999014674.SGD","NDAQ","BK1576","LU0181495838.USD","BK4585","IE00BKPKM429.USD","LU0348735423.USD","SG9999002463.SGD","LU0326950275.SGD","LU0588546209.SGD","IE00B0JY6N72.USD","LU0823426308.USD","LU0979878070.USD","LU2210150020.SGD","LU0043850808.USD","LU0516422440.USD","LU0456846285.SGD","LU2210149790.SGD","LU0307460666.USD","IE00BGHQF748.EUR","BK4139","LU2488822045.USD","02269","LU0572944931.SGD","LU0417516738.SGD","02268","LU0320764599.SGD","LU0359201612.USD","BK4007","LU3063872942.SGD","LU0348825331.USD","LU1880383366.USD","LU0359202008.SGD","LU0516422952.EUR","SG9999014021.USD","SG9999002562.SGD","LU2095319765.USD","LU0327786744.USD","BK1610","SG9999014013.SGD","LU1242518857.USD"],"gpt_icon":0},{"id":"2593418477","title":"WuXi XDC Selected to Manufacture Akari Therapeutics' AKTX-101 for Phase 1 Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2593418477","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593418477?lang=en_us&edition=fundamental","pubTime":"2025-12-23 21:30","pubTimestamp":1766496647,"startTime":"0","endTime":"0","summary":"Akari Therapeutics, Plc has selected WuXi XDC Cayman Inc. as its contract development and manufacturing organization  partner for the GMP manufacturing of AKTX-101, Akari's lead antibody drug conjugate  program. The collaboration aims to support IND-enabling activities and the production of GMP-grade material for a planned Phase 1 first-in-human clinical trial. WuXi XDC will provide end-to-end ADC development and manufacturing services, supporting Akari's clinical development timeline for AKTX-101, which is expected to begin clinical trials in late 2026 or early 2027, pending regulatory clearance.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wuxi XDC Cayman Inc. published the original content used to generate this news brief via Glob","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nNDL4LCcxw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823426480.USD","LU1242518857.USD","02269","BK4007","LU0588546209.SGD","LU0823426308.USD","SG9999014013.SGD","LU0307460666.USD","BK4112","LU0516423174.USD","LU2095319765.USD","LU0359202008.SGD","LU0181495838.USD","IE00B64PRP62.GBP","LU0326950275.SGD","LU0417516902.SGD","LU0516423091.SGD","LU0856984785.SGD","SG9999014674.SGD","LU0348735423.USD","LU0572944931.SGD","LU0314104364.USD","LU0979878070.USD","LU1688375341.USD","BK1589","LU1794554557.SGD","LU0348825331.USD","IE00B3QW5Z07.USD","LU0456846285.SGD","LU0516422440.USD","LU0708995583.HKD","SG9999014005.SGD","LU1242518931.SGD","LU2039709279.SGD","SG9999002562.SGD","LU0052750758.USD","LU0516422366.SGD","AKTX","LU3063872942.SGD","SG9999014039.USD","LU0320764599.SGD","BK4588","02268","NDAQ","BK4585","LU0140636845.USD","LU2210149790.SGD","SG9999014021.USD","IE00BGHQF748.EUR","LU0819121731.USD"],"gpt_icon":0},{"id":"2593418489","title":"Akari Therapeutics Initiates Gmp Manufacturing of Aktx-101 ADC Program to Support Phase 1 First-in-Human Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2593418489","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593418489?lang=en_us&edition=fundamental","pubTime":"2025-12-23 21:30","pubTimestamp":1766496600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nTUA5VKRGW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AKTX","LU2488822045.USD","BK1141","SG9999014674.SGD","02268","BK4139"],"gpt_icon":0},{"id":"1120480059","title":"CMB International: 2025 Medical Insurance Catalog Continues Support for Innovation, Expects CXO Sector Recovery in H2","url":"https://stock-news.laohu8.com/highlight/detail?id=1120480059","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120480059?lang=en_us&edition=fundamental","pubTime":"2025-12-09 10:14","pubTimestamp":1765246458,"startTime":"0","endTime":"0","summary":"CMB International released a research report stating that the 2025 edition of China's basic medical insurance catalog and the first commercial insurance catalog have been announced, continuing to...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999004311.SGD","LU2488822045.USD","BK1521","IE00BZ08YS42.EUR","BK1593","BK1161","LU2328871848.SGD","BK1589","BK1515","LU2097828631.EUR","HK0000165453.HKD","LU2097828557.USD","LU2242644610.SGD","02268","IE00BZ08YT58.USD","LU2097828714.EUR","LU1969619763.USD","LU2097828474.EUR","01801","BK1583","BK1191","CXO","01530","SG9999014674.SGD","LU2097828805.USD","BK1207","01177","IE00BZ08YR35.GBP","LU0455707207.USD","LU0502904849.HKD","BK1141","02273","02367","BK1219"],"gpt_icon":0},{"id":"1189609357","title":"HK Movers | Biomedical Stocks Jump With Ascletis Pharma up 21%, Sirnaomics up 11%","url":"https://stock-news.laohu8.com/highlight/detail?id=1189609357","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189609357?lang=en_us&edition=fundamental","pubTime":"2025-12-09 10:07","pubTimestamp":1765246076,"startTime":"0","endTime":"0","summary":"Biomedical stocks jumped in Hong Kong. Ascletis Pharma rose 21%; Sirnaomics rose 11%; Joinn Laboratories rose 10%; WuXi XDC rose 5%; Pharmaron and WuXi Biologics rose 4%; WuXi AppTec rose 3%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"eb673bcce88aebafcbc37fb491eb2df2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672","02359","02269","02257","06127","02268","03759"],"gpt_icon":0},{"id":"1112154589","title":"BOCOM INTL: China's 1st-8th Batch National Drug Procurement Renewal Rules Likely Moderate, Short-Term Catalysts Ample","url":"https://stock-news.laohu8.com/highlight/detail?id=1112154589","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112154589?lang=en_us&edition=fundamental","pubTime":"2025-12-05 10:48","pubTimestamp":1764902897,"startTime":"0","endTime":"0","summary":"The Hang Seng Healthcare Index rose 0.5% this week, underperforming the broader market. Biopharmaceuticals, prescription drugs, and medical equipment sectors outperformed others. Domestic investors...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","600056","BK0175","BK1141","BK0188","02096","BK0082","BK0185","BK0028","BK0010","SG9999014674.SGD","BK1574","06996","BK1587","BK1593","BK0250","01530","BK1161","BK1191","00013","HK0000165453.HKD","03329","BK1583","BK1147","BK1588","02268"],"gpt_icon":0},{"id":"2589865494","title":"WuXi XDC Cayman Inc.'s (HKG:2268) Stock Has Fared Decently: Is the Market Following Strong Financials?","url":"https://stock-news.laohu8.com/highlight/detail?id=2589865494","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589865494?lang=en_us&edition=fundamental","pubTime":"2025-12-05 06:28","pubTimestamp":1764887330,"startTime":"0","endTime":"0","summary":"WuXi XDC Cayman's (HKG:2268) stock is up by 4.0% over the past three months. Given that the market rewards strong...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2268/wuxi-xdc-cayman-shares/news/wuxi-xdc-cayman-incs-hkg2268-stock-has-fared-decently-is-the","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2268/wuxi-xdc-cayman-shares/news/wuxi-xdc-cayman-incs-hkg2268-stock-has-fared-decently-is-the","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2488822045.USD","SG9999014674.SGD","BK1141","02268"],"gpt_icon":0}],"profile":{"websiteUrl":"http://wuxixdc.com","stockEarnings":[{"period":"1week","weight":0.0658},{"period":"1month","weight":0.0673},{"period":"3month","weight":0.0673},{"period":"6month","weight":0.4727},{"period":"1year","weight":1.426},{"period":"ytd","weight":0.2}],"compareEarnings":[{"period":"1week","weight":0.0296},{"period":"1month","weight":0.0669},{"period":"3month","weight":0.0664},{"period":"6month","weight":0.0845},{"period":"1year","weight":0.396},{"period":"ytd","weight":0.0505}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"WuXi XDC Cayman Inc is an investment holding company principally engaged in the provision of comprehensive contract research, development and manufacturing organization (CRDMO) services for antibody drug conjugate (ADC) and other bioconjugates. The Company's services include the discovery, process development and Good Manufacturing Practice (GMP) manufacturing for bioconjugates, monoclonal antibody intermediates and payload-linkers associated with bioconjugates. The Company provides CRDMO services to customers through contracts under fee-for-service (FFS) basis and contracts under full-time equivalent (FTE) basis. The Company principally conducts its businesses in domestic and overseas markets, including North America, Europe and the rest of the world.","yearOnYearQuotes":[{"month":1,"riseRate":0.222222,"avgChangeRate":0.010265},{"month":2,"riseRate":0.666667,"avgChangeRate":0.058284},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.010372},{"month":4,"riseRate":0.555556,"avgChangeRate":0.03555},{"month":5,"riseRate":0.333333,"avgChangeRate":0.006014},{"month":6,"riseRate":0.4,"avgChangeRate":-0.032735},{"month":7,"riseRate":0.4,"avgChangeRate":0.011785},{"month":8,"riseRate":0.4,"avgChangeRate":-0.114063},{"month":9,"riseRate":0.333333,"avgChangeRate":0.019767},{"month":10,"riseRate":0.777778,"avgChangeRate":0.151657},{"month":11,"riseRate":0.333333,"avgChangeRate":0.008796},{"month":12,"riseRate":0.111111,"avgChangeRate":-0.068876}],"exchange":"SEHK","name":"WUXI XDC","nameEN":"WUXI XDC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"WUXI XDC(02268),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest WUXI XDC(02268) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"WUXI XDC,02268,WUXI XDC股票,WUXI XDC股票老虎,WUXI XDC股票老虎国际,WUXI XDC行情,WUXI XDC股票行情,WUXI XDC股价,WUXI XDC股市,WUXI XDC股票价格,WUXI XDC股票交易,WUXI XDC股票购买,WUXI XDC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"WUXI XDC(02268),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest WUXI XDC(02268) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}